. Docking of the Five Major DXL Conformers Obtained from the MD Simulations ( Figure S4 ) into the Taxane-Binding Site of β-Tubulin as Present in PDB Structure 1JFF and with His229 Protonated on Nε The 250 resulting structures were clustered according to an rmsd criterion of 1.5 Å. Bars represent the number of structures included in each cluster whereas diamonds stand for the mean docking energy of each cluster. The asterisk highlights the solution closest to the TXL conformation found in this PDB entry (Lowe et al. 2001) , which happens to be both the most populated and that giving rise to the most favourable binding energy. The intermolecular van der Waals term (pink) was calculated with the ANAL module in AMBER whereas the solvent-corrected electrostatic interaction (cyan) was computed using the DelPhi program, as described in (Perez et al. 1998 ). 
Supplemental Results

Ligand-Induced Assembly of Tubulin
The compounds were first checked for their ability to induce tubulin assembly under conditions in which tubulin itself is not able to assemble, i.e.
purified GTP-tubulin in a buffer in which tubulin is unable to self-assemble in the absence of ligand (Diaz et al. 1993 ). The critical concentration (Cr) of the assembly reaction was measured for all the ligands (Table S1 ). Compounds 9, 10, 16, 22, 23, 24, 25, 26, 27, 38 and 39 were inactive in these tests (i.e. did not induce tubulin assembly) while the remaining molecules, as well as the three reference taxanes, induced tubulin assembly. We then checked whether the inactive compounds were at least able to further stabilize microtubules in conditions under which they are able to assemble, as is the case for low-affinity taxane mimetics (Buey et al. 2005 ). These molecules were indeed able to reduce the Cr in GAB buffer (Table S1) , which indicates that they can be considered low-affinity microtubule-stabilizing agents (MSA).
The compounds were then evaluated for their dependence on Mg +2 to induce tubulin assembly as well as for their ability to bind dimeric tubulin. As was the case for TXL and its mimetics (Diaz et al. 1993 
Cytotoxicity of CTX-40 on LoVo Cells
The ability of the high-affinity compound CTX-40 to overcome 
Supplemental Discussion
Kinetics of Drug Pumping from the Cells
In order to test the influcence of the different parameters controlling the influx and efflux of the ligands in the amount of bound tubulin, a simplified model of taxane binding to tubulin and P-gp was used.
Schematically, it can be described with the following equations:
where T is tubulin, L, ligand inside the cell, P, P-gp, and O, the ligand outside the cell. K +1 and K +2 the binding affinities for tubulin and P-gp, k +3 and k +4 the kinetic rate constants of the ligand being pumped out, and k +5 and k -5 the kinetic rates of passive ligand influx and efflux. The system was modelled using kinsim in order to study the effects of changes in relative binding affinities between taxanes and microtubules or P-gp.
In this simplified system, the tubulin concentration was considered to be 20 μM, and the passive influx and efflux kinetic rates (k +5 and k -5 ) were set to 0.1 s -1 (compatible with the equilibration time determined for PtK2 cells) Given a certain arbitrary concentration of P-gp (4 μM) it is obvious that it is necessary for the facilitated rates of efflux (k +4 ) to be much higher than the passive ones to have any effect. However, from a certain ratio between the kinetic constants (larger than 1000:1) no effect on the amount of tubulin bound to the ligand is observed ( Figure S5 )
The effect of P-gp overexpression is shown in Figure S6 . In this simple model the amount of liganded tubulin rapidly decreases when P-gp is overexpressed.
However, as expected, the increase in the binding affinity for tubulin μm bead size) developed with a gradient from 50% to 80% of acetonitrile in water, and were found to be greater than 98%, except for CTX-3, CTX-9, 
2'-O-(tert-butyldimethylsilyl)-7-O-triethylsilyltaxol (1)
Taxol (200mg, 0.234mmol) was dissolved in DMF (1.7 ml), then imidazole (84mg, 1.23mmol) and tert-butyldimethylsilyl chloride (TBSCl) (185.4mg, 1.23mmol) were added to the solution, the mixture was reacted for 5 h at room temperature. Additional imidazole (84mg, 1.23mmol) and triethylsilyl chloride (TESCl) (138μl) were added, the mixture was reacted 5 h at room temperature again. Then 100 ml saturated aq NaHCO 3 solution was added, the aqueous layer was extracted with EtOAc (3×150ml), the organic layer was combined, and dried over anhydrous Na 2 SO 4 , then the organic layer was filtered, the filtrate was concentrated to dryness in vacuo. The residue was purified on silica (2) Cephalomannine (600mg, 0.721mmol) was dissolved in DMF (5 ml), then imidazole (245.5mg, 3.61mmol) and tert-butyldimethylsilyl chloride (543.5mg, 3.61 mmol) were added to the solution, the mixture was reacted for 5 h at room temperature. Additional imidazole (245.5mg, 3.61mmol) and triethylsilyl chloride (400μl) were added, the mixture was reacted 5 h at room temperature again. Then 100 ml saturated aq NaHCO 3 solution was added, the aqueous layer was extracted with EtOAc (3×150ml), the organic layer was combined, and dried over anhydrous Na 2 SO 4 , then the organic layer was filtered, the filtrate was concentrated in vacuo. The residue was purified on silica gel with column chromatography (gradient elute with Petroleum ether/acetone = 9/1~4:1) to afford white solid 2'-O-(tert-butyldimethylsilyl)-7-O-triethylsilylcephalomannine (2) (760mg, 99.3%). 
2'-O-(tert-butyldimethylsilyl)-7-O-triethylsilylcephalomannine
was dissolved in dried CH 2 Cl 2 (2 ml), the obtained solution was cooled to -28°C in ice-methanol bath, then the benzyltrimethylammonium hydroxide (Triton B) (93μl, 40% w/w in methanol) was added to the solution, the mixture was stirred for 15 min at -28°C. 10 ml precooled saturated aq NH 4 Cl solution was added, the aqueous layer was extracted with CH 2 Cl 2 (3×50mL), the organic layer was combined, and dried over anhydrous Na 2 SO 4 , then the organic layer was filtered, the filtrate was concentrated to dryness in vacuo, The residue was purified on silica gel by column chromatography (hexane/EtOAc/acetone = 8/3/1) to afford white solid 2'-O-(tert-butyldimethylsilyl)-2-debenzoyl-7-O-triethylsilyltaxol (3) (63.6mg, 65.0%) and recover the starting material (1) (12mg, 12.3%). The product was used in the next step without identification by spectrums.
0.33mmol) was dissolved in dried CH 2 Cl 2 (7 ml), the solution obtained was cooled to -28°C in an ice-methanol bath, then the benzyltrimethylammonium hydroxide (308μl, 40% w/w in methanol) was added to the solution, the mixture was stirred for 15 min at -28°C. 10 mL precooled saturated aq NH 4 Cl solution was added, the aqueous layer was extracted with CH 2 Cl 2 (3×50mL), the organic layer was combined, and dried over anhydrous Na 2 SO 4 , then the organic layer was filtered, the filtrate was concentrated to dryness in vacuo, The residue was purified on silica gel by column chromatography
(209mg, 67.4%) and recover the starting material (2) (58mg, 16.5%). The product was used in the following step without identification by spectrums. was added, the mixture was stirred at 65 °C until the compound (3 or 4) was consumed (TLC analysis). The reaction mixture was diluted with EtOAc(10 mL), filtered through a pad of Celite, and the Celite was washed up with EtOAc (10 mL). The filtrate was concentrated in vacuo to dryness. The residue was purified using PTLC (silica gel, hexane /EtOAc/acetone = 8:3:1) to afford 5 or 6.
General Procedure for the Preparation of
Although it was found that the products were contaminated with DCU by 1 HNMR, they were subjected to desilylation without further purification. (8) 2'-(tert-butyldimethylsilyl)-10-deacetylcephalomannine (7) (198mg, 0.22mmol) was dissolved in THF (6 ml), then propionic anhydride (280μl, 2.2mmol) and (16mg, 0.07mmol) were added to the solution, the mixture was reacted for 2 h at room temperature. The mixture was diluted with EtOAc (30 ml), then washed by saturated aq NaHCO 3 solution (30 ml), the aqueous layer was extracted with EtOAc (3×50mL), the organic layer was combined, and dried over anhydrous Na 2 SO 4 , then the organic layer was filtered, the filtrate was concentrated in vacuo. The residue was purified on silica gel by column chromatography (Petroleum ether/EtOAc = 4/1) to afford white solid 2'-O-(tert-butyldimethylsilyl)-10-propionyl-10-deacetylcephalomannine 
2'-O-(tert-butyldimethylsilyl)-2-debenzoyl-7-O-triethylsilyl-10-propionyl-10-de acetylcephalomannine (10)
2'-O-(tert-butyldimethylsilyl)-7-O-triethylsilyl-10-propionyl-10-deacetylceph alomannine (9) (83mg, 0.077mmol) was dissolved in dried CH 2 Cl 2 (2.5 mL), the obtained solution was cooled to -28°C in ice-methanol bath, then the benzyltrimethylammonium hydroxide (68μl, 40% w/w in methanol) was added to the solution, the mixture was stirred for 35 min at -28°C. 20 mL precooled saturated aq NH 4 Cl solution was added, the aqueous layer was extracted with CH 2 Cl 2 (3×30mL), the organic layer was combined, and dried over anhydrous 10-propionyl-10-deacetylbaccatin (III) (13) 10-deacetylbaccatin (III) (12) (21.7mg, 0.04mmol) was dissolved in THF (1.2 ml), then propionic anhydride (51.4μl, 0.4mmol) and CeCl 3 (2mg, 0.002mmol) were added to the solution, the mixture was reacted for 2 h at 35°C.
CTX-20:
10 ml saturated aq NaHCO 3 solution was added, the aqueous layer was extracted with EtOAc (3×20mL), the organic layer was combined, then dried over anhydrous Na 2 SO 4 , and filtered, the filtrate was concentrated in vacuo.
Purification of the residue was carried out using preparation thin layer chromatography (PTLC) (Petroleum ether/EtOAc = 1/3) to afford white solid 
7-O-triethylsilyl-10-propionyl-10-deacetylbaccatin(III) (14)
10-propionyl-10-deacetylbaccatin(III) (13) (198mg, 0.33mmol) was dissolved in DMF (3 ml), then imidazole (180mg, 2.64mmol) and triethylsilyl chloride (360μl, 2.15mmol) were added to the solution, the mixture was reacted for 1.5 h at room temperature. 20 ml saturated aq NH 4 Cl solution was added, the aqueous layer was extracted with EtOAc (3×50mL), the organic layer was combined, then dried over anhydrous Na 2 SO 4 , and filtered, the filtrate was concentrated in vacuo. Purification of the residue was carried out using PTLC 7-O-triethylsilyl-10-propionyldocetaxel (17) 2',7-O-di(triethylsilyl)-10-propionyldocetaxel (16) (19mg, 0.017mmol) was dissolved in acetonitrile (2 ml), then pyridine (80μl, 0.99mmol) and HF(44μl, 0.99mmol) was added to the solution in turn, the mixture was stirred for 15 min at room temperature. 15 ml saturated aq NaHCO 3 solution was added, the aqueous layer was extracted with EtOAc (3×50mL), the organic layer was combined, then dried over anhydrous Na 2 SO 4 , and filtered, the filtrate was 7-O-triethylsilyl-10-propionyldocetaxel (17) (89mg, 0.091mmol) was dissolved in DMF (0.5 ml), then imidazole (43.4mg, 0.64mmol) and tert-butyldimethylsilyl chloride (68.5mg, 0.46mmol) was added to the solution in turn, the mixture was stirred for 5 h at room temperature. 30 ml saturated aq NaCl solution was added, the aqueous layer was extracted with EtOAc (3×50mL), the organic layer was combined, then dried over anhydrous Na 2 SO 4 , and filtered, the filtrate was concentrated to dryness in vacuo, The residue was 
(50mg, 0.046mmol) was dissolved in dried CH 2 Cl 2 (2.4 ml), the solution obtained was cooled to -28°C in ice-methanol bath, then the benzyltrimethylammonium hydroxide (45μl, 40% w/w in methanol) was added to the solution, the mixture was stirred for 15 min at -28°C. 10 ml precooled saturated aq NH 4 Cl solution was added, the aqueous layer was extracted with EtOAc (3×30mL), the organic layer was combined, then dried over anhydrous Na 2 SO 4 , and filtered, the filtrate was concentrated to dryness in vacuo, The residue was purified on silica gel by column chromatography (Petroleum ether/EtOAc/acetone = 8/3/1) to afford white solid 2'-O-(tert-butyldimethylsilyl)-2-debenzoyl-7-O-triethylsilyl-10-propionyldocetaxel (19) (24mg, 53.1%) and recover the starting material (18) (12mg, 24%) room temperature until the protecting groups were removed completely. 50 ml EtOAc was added, the organic layer was washed with saturated aq NaHCO 3 solution(2×20mL), the aqueous layer was extracted with EtOAc (3×50mL), the organic layer was combined, then dried over anhydrous Na 2 SO 4 , and filtered, the filtrate was concentrated in vacuo, and the residual pyridine was removed by forming azeotropic mixture with cyclohexane. The residue was purified on silica gel by column chromatography (n-hexane/acetone = 2/1) to afford white solids CTX-40 (7.6mg, 51%, two steps). For the synthesis and characterizations of CTX-1 to -10, -28 to -36, -41, please refer to (Yang et al. 2007 ).
For the synthesis and characterizations of CTX-22, -23, -26 and -27, please refer to the supplemental materials in (Wang et al. 2007 ).
Cell Biology Studies
LoVo and P-gp-overexpressing LoVo-Dox (Grandi et al. 1986 ) cells were Waals interaction energies between CTX-40 and individual residues were calculated with the ANAL module of AMBER, whereas the solvent-corrected electrostatic interaction was computed using the DelPhi program, as described in (Perez et al. 1998 ).
NMR Experiments
TR-NOESY experiments were performed with mixing times of 50 and 200 ms. To fit the experimental TRNOE intensities, off-rate constants between 10-500 s -1 were tested. Optimal agreement was achieved for k off values ranging from 15 to 150 s -1 .
The fitting of the theoretical NOE values to the experimental NOE ones was performed using the CORCEMA programme, which considers a full relaxation matrix for the ligand protons in the presence of exchange between the free and bound forms. Thus, different average rotational correlation times (from 10 to 1000 ns) were used to fit the data and 100 ns was found to provide the best match between the experimental and expected values. It has to be considered that this value is in fact an "effective" correlation time, which contains contributions from global and internal motions.
